✦ LIBER ✦

P335 Study on the safety and efficacy of sitafloxacin 100 mg once-daily (use-results survey: interim results)

✍ Scribed by Hori, S.; Matsumoto, T.; Uchino, K.; Yamaguchi, H.; Takahashi, M.; Hamajima, S.; Nukui, K.; Eda, H.; Takita, A.; Yamanouchi, N.; Shiozawa, T.; Okutani, Y.

Book ID: 122907613
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 90 KB
Volume: 42
Category: Article
ISSN: 0924-8579
DOI: 10.1016/S0924-8579(13)70576-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical efficacy and safety of telmisar

Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study

✍ L. Alcocer; P. Fernandez-Bonetti; E. Campos; R. Dominguez-Henkel; J.J. DE La Fue 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

458 FINAL RESULTS OF THE PHARMACOKINETIC

458 FINAL RESULTS OF THE PHARMACOKINETICS, EFFICACY, AND SAFETY/TOLERABILITY OF 400 AND 600 MG ONCE-DAILY DOSING OF ACH-1625 (HCV NS3 PROTEASE INHIBITOR) IN HCV GENOTYPE 1

✍ V. Detishin; W. Haazen; R. Hooijmaijers; M. Ruppert; K. Bol; H. Robison; L. Roba 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Once-daily atazanavir/ritonavir versus t

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Efficacy, safety and tolerability of riv

Efficacy, safety and tolerability of rivastigmine patch 13.3 mg/24 h (15 cm2) versus 4.6 mg/24 h (5 cm2) in patients with severe Alzheimer's disease: Results of the ACTivities of daily living and cognitION (ACTION) study

✍ Farlow, Martin; Meng, Xiangyi; Rensch, Scott; Somogyi, Monique 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy, safety and tolerability of riv

Efficacy, safety and tolerability of rivastigmine patch 13.3 mg/24 h (15 cm2) versus 4.6 mg/24 h (5 cm2) in patients with severe Alzheimer's disease: results of the ACTivities of daily living and cognitION (ACTION) study

✍ Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 61 KB